Reneural
PrivateLast Round
Grant
Nov 6, 2024
Total Funding Raised
$1.02M
Company Overview
Reneural is a neurotech company that develops a neurorehabilitation platform using virtual reality designed for stroke survivors.
Sector
Healthcare & Life Sciences
Verticals
AR/VR Experiences, Mental Health, Patient Engagement, Clinical Trials
Business Model
B2B
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reneural Comparables
Compare Reneural with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eXRt Intelligent Healthcare | 92% | |
| Eodyne Systems | 84% | |
| Neuro Rehab VR | 82% | |
Reneural Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 6, 2024 | ||||
| Pre Seed | Nov 6, 2024 | ||||
| Grant | Nov 1, 2022 |
Reneural Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant, Pre Seed |
| SFC Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 141% MoM, reaching 2.6K.
- Nov 6, 2024
$255K raised in Pre Seed round.
Reneural Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reneural's valuation, stock price, and market status.